OPTN/UNOS database, investigators studied the prevalence of urologic malignancies among US kidney transplant recipients.

Knowledge of clinician- and parent-perceived barriers for Black and Hispanic children offers opportunities to increase equitable trial participation.

The latest systematic review on kidney tumor enucleation vs partial nephrectomy includes robot-assisted series and randomized trials.

Cancer-attributable medical service costs highest in end-of-life phase; oral prescription drug costs rising, especially in EOL.

A phase 3 randomized controlled trial tested specialized immunonutrition vs standard nutrition before radical cystectomy for ...

The Revi® Extend Implant by BlueWind Medical has received US FDA 510(k) clearance. It’s a next-generation implantable tibial neuromodulator for urge urinary incontinence that f ...

The FDA has approved Pluvicto plus ARPI therapy for adults with PSMA-positive metastatic androgen pathway modulation-naive/sensitive prostate cancer.

(HealthDay News) — Under updated hypertension guidelines, about one-third of adults with hypertension are newly eligible for therapy, but 43 percent remain untreated, according to a study published ...

Prospective registry data describe oncologic outcomes up to 10 years after focal HIFU or cryotherapy for prostate cancer.

Investigators assessed the risk of VEGF-related adverse outcomes, such as cancer, among patients with chronic kidney disease (CKD) taking HIF-PHI drugs.

The U.S. Federal Trade Commission (FTC) has sued telehealth company Hims & Hers, alleging it shared consumers’ private health information with advertising platforms and unknowingly charged some ...

Study findings reveal an overlooked immune cell population that might contribute to renal injury in lupus nephritis.